Skip to main content

Casellas Alberto's Form 4 filing

Synchrony Financial (SYF) · filed Mar 5, 2024

Accession no.
0001601712-24-000110
Filed
Mar 5, 2024
Trade date
Mar 1-5, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.97M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casellas AlbertoCIK 0001763554Officer (See remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 1, 2024Common StockFTax withholdingDisposed−13,684$41.05−$561,728.280,822Direct
Mar 1, 2024Common StockAGrant or awardAcquired+27,817$41.05+$1,141,887.85108,639Direct
Mar 5, 2024Common StockMOption exerciseAcquired+23$23.00+$529108,662Direct
Mar 5, 2024Common StockMOption exerciseAcquired+3,774$24.55+$92,651.7112,436Direct
Mar 5, 2024Common StockSSaleDisposed−41,513$40.50−$1,681,276.570,923Direct
Mar 5, 2024Common StockSSaleDisposed−6,956$41.25−$286,93563,967Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 5, 2024Common StockMOption exerciseDisposed−23$0.00$00Direct
Mar 5, 2024Common StockMOption exerciseDisposed−3,774$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

EVP, CEO--Health & Wellness

Read the full filing on SEC EDGAR (opens in a new tab)